Literature DB >> 25160675

Development and validation of a UPLC method for rapid and simultaneous analysis of proton pump inhibitors.

Richard T Addo1, Kenneth Davis, Ruhi Ubale, Joel S Owen, E Blake Watkins.   

Abstract

Proton pump inhibitors (PPIs) are used extensively for the relief of gastroesophageal reflux, peptic ulcers, and other hypersecretory conditions. Some of the commonly used PPIs-omeprazole, esomeprazole, lansoprazole, pantoprazole, and rabeprazole-were used in this study with the aim of developing a rapid ultra performance liquid chromatography (UPLC) method for detecting each and allowing separation and quantification of a mixture of PPIs. An analysis of samples was performed on a UPLC system equipped with a quaternary solvent delivery system, a refrigerated sample manager, a column heater, a photo diode array detector scanning from 210 to 400 nm, and a C18 analytical column (50 mm × 3.0 mm, 1.7-μm particle size). The chromatographic analysis of the PPI samples and standards was performed using gradient elution with acetonitrile and water. The calibration curve range varied for each of the PPIs ranging from a lower limit of 0.75-1.78 μg/mL to a maximum concentration of 200 μg/mL with a regression coefficient (r (2)) of ≥0.98. The accuracy and precision were calculated, and the %RSD was determined to be ≤0.21% (intraday) and ≤5% (interday). The LOD was 0.23-0.59 μg/mL and the LOQ was 0.71-1.78 μg/mL for each of the drugs analyzed. The method was capable of detecting and quantifying each drug in a mixture with good resolution and a total run time of less than 5 min. Herein, we report an efficient and rapid analytical method for the simultaneous detection of multiple PPIs in a mixture.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25160675      PMCID: PMC4309820          DOI: 10.1208/s12249-014-0207-7

Source DB:  PubMed          Journal:  AAPS PharmSciTech        ISSN: 1530-9932            Impact factor:   3.246


  14 in total

1.  Improved HPLC method for determination of four PPIs, omeprazole, pantoprazole, lansoprazole and rabeprazole in human plasma.

Authors:  Maryam Noubarani; Fariborz Keyhanfar; Manijeh Motevalian; Masoud Mahmoudian
Journal:  J Pharm Pharm Sci       Date:  2010       Impact factor: 2.327

2.  Improving LC-MS sensitivity through increases in chromatographic performance: comparisons of UPLC-ES/MS/MS to HPLC-ES/MS/MS.

Authors:  Mona I Churchwell; Nathan C Twaddle; Larry R Meeker; Daniel R Doerge
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2005-07-05       Impact factor: 3.205

3.  High-throughput quantification for a drug mixture in rat plasma-a comparison of Ultra Performance liquid chromatography/tandem mass spectrometry with high-performance liquid chromatography/tandem mass spectrometry.

Authors:  Kate Yu; David Little; Rob Plumb; Brian Smith
Journal:  Rapid Commun Mass Spectrom       Date:  2006       Impact factor: 2.419

Review 4.  Recent advances in high-throughput quantitative bioanalysis by LC-MS/MS.

Authors:  Raymond Naxing Xu; Leimin Fan; Matthew J Rieser; Tawakol A El-Shourbagy
Journal:  J Pharm Biomed Anal       Date:  2007-02-13       Impact factor: 3.935

Review 5.  UPLC: a preeminent technique in pharmaceutical analysis.

Authors:  Ashok Kumar; Gautam Saini; Anroop Nair; Rishbha Sharma
Journal:  Acta Pol Pharm       Date:  2012 May-Jun       Impact factor: 0.330

6.  Simultaneous screening and quantification of 52 common pharmaceuticals and drugs of abuse in hair using UPLC-TOF-MS.

Authors:  Marie Katrine Klose Nielsen; Sys Stybe Johansen; Petur Weihe Dalsgaard; Kristian Linnet
Journal:  Forensic Sci Int       Date:  2010-01-12       Impact factor: 2.395

7.  Simultaneous screening and quantification of 29 drugs of abuse in oral fluid by solid-phase extraction and ultraperformance LC-MS/MS.

Authors:  Nora Badawi; Kirsten Wiese Simonsen; Anni Steentoft; Inger Marie Bernhoft; Kristian Linnet
Journal:  Clin Chem       Date:  2009-10-01       Impact factor: 8.327

8.  Identification of two main urinary metabolites of [14C]omeprazole in humans.

Authors:  L Renberg; R Simonsson; K J Hoffmann
Journal:  Drug Metab Dispos       Date:  1989 Jan-Feb       Impact factor: 3.922

9.  Effects of clarithromycin on lansoprazole pharmacokinetics between CYP2C19 genotypes.

Authors:  Masato Saito; Norio Yasui-Furukori; Tsukasa Uno; Takenori Takahata; Kazunobu Sugawara; Akihiro Munakata; Tomonori Tateishi
Journal:  Br J Clin Pharmacol       Date:  2005-03       Impact factor: 4.335

10.  RP-UPLC method development and validation for the simultaneous estimation of ibuprofen and famotidine in pharmaceutical dosage form.

Authors:  Yarram Ramakoti Reddy; Kakumani Kishore Kumar; Mrp Reddy; K Mukkanti
Journal:  Pharm Methods       Date:  2012-07
View more
  1 in total

1.  Simultaneous Quantitative Analysis of Six Proton-Pump Inhibitors with a Single Marker and Evaluation of Stability of Investigated Drugs in Polypropylene Syringes for Continuous Infusion Use.

Authors:  Fuchao Chen; Xudong He; Baoxia Fang; Sicen Wang
Journal:  Drug Des Devel Ther       Date:  2020-12-24       Impact factor: 4.162

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.